Drug Trials Snapshots: ROZLYTREK

ROZLYTREK is a drug used to treat adult patients with a type of non-small cell lung cancer (NSCLC) which is caused by an abnormal ROS1 gene and, has spread to other parts of the body (metastatic)

Source: FDA Center for Drug Evaluation and Research - What's New - January 27, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news